FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 355:896-908 August 31, 2006 Number 9 Next

	Full Text PDF PDA Full Text PowerPoint Slide Set Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article PubMed Citation

ABSTRACT

Background Neurostimulation of the subthalamic nucleus reduces levodopa-related motor complications in advanced Parkinson's disease. We compared this treatment plus medication with medical management.

Methods In this randomized-pairs trial, we enrolled 156 patients with advanced Parkinson's disease and severe motor symptoms. The primary end points were the changes from baseline to six months in the quality of life, as assessed by the Parkinson's Disease Questionnaire (PDQ-39), and the severity of symptoms without medication, according to the Unified Parkinson's Disease Rating Scale, part III (UPDRS-III).

Results Pairwise comparisons showed that neurostimulation, as compared with medication alone, caused greater improvements from baseline to six months in the PDQ-39 (50 of 78 pairs, P=0.02) and the UPDRS-III (55 of 78, P<0.001), with mean improvements of 9.5 and 19.6 points, respectively. Neurostimulation resulted in improvements of 24 to 38 percent in the PDQ-39 subscales for mobility, activities of daily living, emotional well-being, stigma, and bodily discomfort. Serious adverse events were more common with neurostimulation than with medication alone (13 percent vs. 4 percent, P<0.04) and included a fatal intracerebral hemorrhage. The overall frequency of adverse events was higher in the medication group (64 percent vs. 50 percent, P=0.08).

Conclusions In this six-month study of patients under 75 years of age with severe motor complications of Parkinson's disease, neurostimulation of the subthalamic nucleus was more effective than medical management alone. (ClinicalTrials.gov number, NCT00196911 [ClinicalTrials.gov] .)

Source Information

From Christian Albrechts University, Kiel (G.D., P.K., J.V., C.D., W.H., J.H., S.K., D.L., H.M.M., M.O.P.); Philipps University, Marburg (C.S.-B., H.S., W.O., A.R.); Ludwig Maximilians University, Munich (K.B., A.D., S.L., U.S.); Homburg University, Homburg (U.D., J.R.M.); Charité Hospital, Humboldt University, Berlin (D.G., A.K., G.-H.S., T.T.); Cologne University, Cologne, (R.H., V.S., J.V.); Heidelberg University, Heidelberg (M.Kloß, M.Krause, V.T.); Dresden University, Dresden (J.K., H.R.); and Heinrich Heine University, Dusseldorf (A.S., L.T., L.W.) — all in Germany; and Innsbruck Medical University, Innsbruck, Austria (W.E., E.W., W.P.).

Address reprint requests to Dr. Deuschl at the Department of Neurology, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Christian Albrechts University, Schittenhelmstrasse 10, 24105 Kiel, Germany, or at g.deuschl{at}neurologie.uni-kiel.de.

Full Text of this Article

Related Letters:

Deep-Brain Stimulation for Parkinson's Disease
Lieb K., Schlaepfer T. E., Deuschl G., Volkmann J.
Extract | Full Text | PDF  
N Engl J Med 2006; 355:2256, Nov 23, 2006. Correspondence

This article has been cited by other articles:

• Christine, C. W., Starr, P. A., Larson, P. S., Eberling, J. L., Jagust, W. J., Hawkins, R. A., VanBrocklin, H. F., Wright, J. F., Bankiewicz, K. S., Aminoff, M. J. (2009). Safety and tolerability of putaminal AADC gene therapy for Parkinson disease. Neurology 73: 1662-1669 [Abstract] [Full Text]  
• Groiss, S.J., Wojtecki, L., Sudmeyer, M., Schnitzler, A. (2009). Review: Deep brain stimulation in Parkinson's disease. Therapeutic Advances in Neurological Disorders 2: 379-391 [Abstract]  
• Deligny, C., Drapier, S., Verin, M., Lajat, Y., Raoul, S., Damier, P. (2009). BILATERAL SUBTHALAMOTOMY THROUGH DBS ELECTRODES: A RESCUE OPTION FOR DEVICE-RELATED INFECTION. Neurology 73: 1243-1244 [Full Text]  
• Temel, Y., Tan, S., Visser-Vandewalle, V., Sharp, T. (2009). Parkinson's disease, DBS and suicide: a role for serotonin?. Brain 132: e126-e126 [Full Text]  
• Ferraye, M. U., Debu, B., Fraix, V., Goetz, L., Ardouin, C., Yelnik, J., Henry-Lagrange, C., Seigneuret, E., Piallat, B., Krack, P., Le Bas, J.-F., Benabid, A.-L., Chabardes, S., Pollak, P. (2009). Effects of pedunculopontine nucleus area stimulation on gait disorders in Parkinson's disease. Brain 0: awp229v1-awp229 [Abstract] [Full Text]  
• Esselink, R.A.J., de Bie, R. M.A., de Haan, R. J., Lenders, M. W.P.M., Nijssen, P. C.G., van Laar, T., Schuurman, P. R., Bosch, D. A., Speelman, J. D. (2009). LONG-TERM SUPERIORITY OF SUBTHALAMIC NUCLEUS STIMULATION OVER PALLIDOTOMY IN PARKINSON DISEASE. Neurology 73: 151-153 [Full Text]  
• Okun, M. S., Foote, K. D. (2009). Enough Is Enough: Moving on to Deep Brain Stimulation in Patients With Fluctuating Parkinson Disease. Arch Neurol 66: 778-780 [Full Text]  
• Olanow, C. W., Stern, M. B., Sethi, K. (2009). The scientific and clinical basis for the treatment of Parkinson disease (2009). Neurology 72: S1-S136 [Abstract] [Full Text]  
• Bannier, S, Montaurier, C, Derost, P P, Ulla, M, Lemaire, J-J, Boirie, Y, Morio, B, Durif, F (2009). Overweight after deep brain stimulation of the subthalamic nucleus in Parkinson disease: long term follow-up. J. Neurol. Neurosurg. Psychiatry 80: 484-488 [Abstract] [Full Text]  
• Weaver, F. M., Follett, K., Stern, M., Hur, K., Harris, C., Marks, W. J. Jr, Rothlind, J., Sagher, O., Reda, D., Moy, C. S., Pahwa, R., Burchiel, K., Hogarth, P., Lai, E. C., Duda, J. E., Holloway, K., Samii, A., Horn, S., Bronstein, J., Stoner, G., Heemskerk, J., Huang, G. D., for the CSP 468 Study Group, (2009). Bilateral Deep Brain Stimulation vs Best Medical Therapy for Patients With Advanced Parkinson Disease: A Randomized Controlled Trial. JAMA 301: 63-73 [Abstract] [Full Text]  
• Deuschl, G. (2009). Neurostimulation for Parkinson Disease. JAMA 301: 104-105 [Full Text]  
• Voon, V., Krack, P., Lang, A. E., Lozano, A. M., Dujardin, K., Schupbach, M., D'Ambrosia, J., Thobois, S., Tamma, F., Herzog, J., Speelman, J. D., Samanta, J., Kubu, C., Rossignol, H., Poon, Y.-Y., Saint-Cyr, J. A., Ardouin, C., Moro, E. (2008). A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease. Brain 131: 2720-2728 [Abstract] [Full Text]  
• Hilker, R., Voges, J., Weber, T., Kracht, L. W., Roggendorf, J., Baudrexel, S., Hoevels, M., Sturm, V., Heiss, W. D. (2008). STN-DBS activates the target area in Parkinson disease: An FDG-PET study. Neurology 71: 708-713 [Abstract] [Full Text]  
• Baup, N., Grabli, D., Karachi, C., Mounayar, S., Francois, C., Yelnik, J., Feger, J., Tremblay, L. (2008). High-Frequency Stimulation of the Anterior Subthalamic Nucleus Reduces Stereotyped Behaviors in Primates. J. Neurosci. 28: 8785-8788 [Abstract] [Full Text]  
• York, M K, Dulay, M, Macias, A, Levin, H S, Grossman, R, Simpson, R, Jankovic, J (2008). Cognitive declines following bilateral subthalamic nucleus deep brain stimulation for the treatment of Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 79: 789-795 [Abstract] [Full Text]  
• Anheim, M., Batir, A., Fraix, V., Silem, M., Chabardes, S., Seigneuret, E., Krack, P., Benabid, A.-L., Pollak, P. (2008). Improvement in Parkinson Disease by Subthalamic Nucleus Stimulation Based on Electrode Placement: Effects of Reimplantation. Arch Neurol 65: 612-616 [Abstract] [Full Text]  
• Papapetropoulos, S., Jagid, J. R., Sengun, C., Singer, C., Gallo, B. V. (2008). Objective monitoring of tremor and bradykinesia during DBS surgery for Parkinson disease. Neurology 70: 1244-1249 [Abstract] [Full Text]  
• Moro, E., Volkmann, J., Konig, I. R., Winkler, S., Hiller, A., Hassin-Baer, S., Herzog, J., Schnitzler, A., Lohmann, K., Pinsker, M. O., Voges, J., Djarmatic, A., Seibler, P., Lozano, A. M., Rogaeva, E., Lang, A. E., Deuschl, G., Klein, C. (2008). Bilateral subthalamic stimulation in Parkin and PINK1 parkinsonism. Neurology 70: 1186-1191 [Abstract] [Full Text]  
• Herzog, J., Weiss, P. H., Assmus, A., Wefer, B., Seif, C., Braun, P. M., Pinsker, M. O., Herzog, H., Volkmann, J., Deuschl, G., Fink, G. R. (2008). Improved sensory gating of urinary bladder afferents in Parkinson's disease following subthalamic stimulation. Brain 131: 132-145 [Abstract] [Full Text]  
• McCracken, C. B., Grace, A. A. (2007). High-Frequency Deep Brain Stimulation of the Nucleus Accumbens Region Suppresses Neuronal Activity and Selectively Modulates Afferent Drive in Rat Orbitofrontal Cortex In Vivo. J. Neurosci. 27: 12601-12610 [Abstract] [Full Text]  
• Temel, Y., Boothman, L. J., Blokland, A., Magill, P. J., Steinbusch, H. W. M., Visser-Vandewalle, V., Sharp, T. (2007). Inhibition of 5-HT neuron activity and induction of depressive-like behavior by high-frequency stimulation of the subthalamic nucleus. Proc. Natl. Acad. Sci. USA 104: 17087-17092 [Abstract] [Full Text]  
• Devos, H., Vandenberghe, W., Nieuwboer, A., Tant, M., Baten, G., De Weerdt, W. (2007). Predictors of fitness to drive in people with Parkinson disease. Neurology 69: 1434-1441 [Abstract] [Full Text]  
• Schapira, A. H. V. (2007). Treatment Options in the Modern Management of Parkinson Disease. Arch Neurol 64: 1083-1088 [Full Text]  
• Ludwig, J., Remien, P., Guballa, C., Binder, A., Binder, S., Schattschneider, J., Herzog, J., Volkmann, J., Deuschl, G., Wasner, G., Baron, R. (2007). Effects of subthalamic nucleus stimulation and levodopa on the autonomic nervous system in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 78: 742-745 [Abstract] [Full Text]  
• Riley, D., Lozano, A. (2007). The fourth dimension of stereotaxis: Timing of neurosurgery for Parkinson disease. Neurology 68: 252-253 [Full Text]  
• (2006). CARPHOLOGY by Rajendra. PN 6: 400-400 [Full Text]  
• Lieb, K., Schlaepfer, T. E., Deuschl, G., Volkmann, J. (2006). Deep-brain stimulation for Parkinson's disease.. NEJM 355: 2256-2256 [Full Text]  
• (2006). Subthalamic Deep Brain Stimulation vs. Best Medical Therapy for Parkinson Disease. JWatch Neurology 2006: 4-4 [Full Text]  
• (2006). Deep-Brain Stimulation for Parkinson Disease. JWatch General 2006: 3-3 [Full Text]  
• Fister, K. (2006). What's new in the other general journals. BMJ 333: 542-543 [Full Text]